Institute for International Research

PharmaNet Development Group is a global, drug development corporation providing a comprehensive range of services to the pharmaceutical, biotechnology, generic drug, and medical device industries. PharmaNet companies offer clinical-development solutions from consulting to early stage clinical studies and bioanalytical analyses, through Phase II and III clinical development programs, to Phase IV programs supporting the commercialization of marketed products. With approximately 2,300 employees in more than 35 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development.

Covance - one of the world's largest and most comprehensive drug development services companies - has the people, global resources and problem-solving culture to respond to pharmaceutical and biotechnology clients' toughest drug development challenges. We provide a portfolio of preclinical and clinical development and commercial service offerings - delivered through industry-leading nonclinical testing services, the world's largest central laboratory network, and a global team of clinical trial professionals and cardiac safety experts. Covance maintains global operations in more than 20 countries, and has more than 8,700 employees worldwide.